Development of an indirect competitive ELISA for simultaneous detection of enrofloxacin and ciprofloxacin

J Zhejiang Univ Sci B. 2011 Nov;12(11):884-91. doi: 10.1631/jzus.B1100076.

Abstract

Modified 1-ethyl-3-(3-dimethylaminopropy) carbodiimide (EDC) method was employed to synthesize the artificial antigen of enrofloxacin (ENR), and New Zealand rabbits were used to produce anti-ENR polyclonal antibody (pAb). Based on the checkerboard titration, an indirect competitive enzyme-linked immunosorbent assay (ELISA) standard curve was established. This assay was sensitive and had a linear range from 0.6 to 148.0 μg/kg (R(2) = 0.9567), with the half maximal inhibitory concentration (IC(50)) and limit of detection (LOD) values of 9.4 μg/kg and 0.2 μg/kg, respectively. Of all the competitive analogues, the produced pAb exhibited a high cross-reactivity to ciprofloxacin (CIP) (87%), the main metabolite of ENR in tissues. After optimization, the matrix effects can be ignored using a 10-fold dilution in beef and 20-fold dilution in pork. The overall recoveries and coefficients of variation (CVs) were in the ranges of 86%-109% and 6.8%-13.1%, respectively. It can be concluded that the established ELISA method is suitable for simultaneous detection of ENR and CIP in animal tissues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Infective Agents / analysis*
  • Cattle
  • Ciprofloxacin / analysis*
  • Enrofloxacin
  • Enzyme-Linked Immunosorbent Assay / methods*
  • Fluoroquinolones / analysis*
  • Limit of Detection
  • Meat / analysis*
  • Rabbits
  • Swine

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • Enrofloxacin
  • Ciprofloxacin